Canandaigua National Bank & Trust’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8M Buy
+83,853
New +$9.81M 0.91% 23
2025
Q4
$9.51M Sell
90,387
-1,556
-2% -$146K 0.85% 24
2025
Q3
$7.72M Sell
91,943
-4,134
-4% -$340K 0.68% 29
2025
Q2
$7.61M Buy
96,077
+8,282
+9% +$658K 0.7% 30
2025
Q1
$7.88M Buy
87,795
+8,268
+10% +$772K 0.79% 27
2024
Q4
$7.91M Buy
79,527
+467
+0.6% +$48.1K 0.78% 27
2024
Q3
$8.98M Sell
79,060
-1,970
-2% -$234K 0.85% 24
2024
Q2
$10M Sell
81,030
-625
-0.8% -$80.5K 1.09% 18
2024
Q1
$10.8M Sell
81,655
-2,136
-3% -$263K 1.59% 11
2023
Q4
$9.13M Sell
83,791
-2,497
-3% -$259K 1.41% 14
2023
Q3
$8.88M Sell
86,288
-6,972
-7% -$751K 1.44% 14
2023
Q2
$10.8M Sell
93,260
-9,672
-9% -$1.1M 1.74% 9
2023
Q1
$11M Buy
+102,932
New +$11.1M 1.84% 7
2020
Q1
$7.08M Buy
96,410
+2,377
+3% +$187K 1.5% 11
2019
Q4
$8.16M Sell
94,033
-1,228
-1% -$101K 1.38% 14
2019
Q3
$7.65M Buy
95,261
+2,453
+3% +$197K 1.35% 17
2019
Q2
$7.43M Buy
92,808
+2,585
+3% +$198K 1.37% 17
2019
Q1
$7.16M Sell
90,223
-2,539
-3% -$190K 1.37% 17
2018
Q4
$6.76M Sell
92,762
-887
-0.9% -$62.6K 1.43% 16
2018
Q3
$6.34M Sell
93,649
-445
-0.5% -$28.4K 1.13% 15
2018
Q2
$5.45M Buy
94,094
+298
+0.3% +$16.8K 1.05% 19
2018
Q1
$4.88M Buy
93,796
+1,880
+2% +$102K 0.62% 40
2017
Q4
$4.93M Buy
91,916
+2,578
+3% +$143K 0.89% 30
2017
Q3
$5.46M Buy
89,338
+11,080
+14% +$672K 1.04% 26
2017
Q2
$4.79M Sell
78,258
-1,093
-1% -$66.5K 0.98% 28
2017
Q1
$4.81M Sell
79,351
-3,302
-4% -$200K 1.42% 20
2016
Q4
$4.64M Buy
82,653
+3,648
+5% +$213K 1.39% 18
2016
Q3
$4.71M Buy
79,005
+3,656
+5% +$214K 1.36% 22
2016
Q2
$4.14M Buy
75,349
+1,002
+1% +$53.3K 1.18% 26
2016
Q1
$3.75M Buy
74,347
+2,995
+4% +$147K 1.1% 28
2015
Q4
$3.6M Buy
71,352
+431
+0.6% +$21.7K 1.1% 27
2015
Q3
$3.34M Sell
70,921
-1,103
-2% -$58.6K 1.07% 28
2015
Q2
$3.91M Buy
72,024
+5,830
+9% +$327K 1.15% 25
2015
Q1
$3.63M Buy
66,194
+6,649
+11% +$376K 1.09% 26
2014
Q4
$3.23M Sell
59,545
-1,475
-2% -$82.2K 1.03% 28
2014
Q3
$3.45M Sell
61,020
-1,357
-2% -$76.2K 1.14% 21
2014
Q2
$3.44M Sell
62,377
-1,577
-2% -$86K 1.14% 22
2014
Q1
$3.46M Sell
63,954
-686
-1% -$35.5K 1.17% 22
2013
Q4
$3.09M Sell
64,640
-2,248
-3% -$103K 1.09% 26
2013
Q3
$3.04M Buy
66,888
+1,501
+2% +$68.5K 1.16% 22
2013
Q2
$2.9M Buy
+65,387
New +$2.92M 1.13% 25

Other funds holding MRK

Canandaigua National Bank & Trust's MRK Position: Q2 2026 in Review

Canandaigua National Bank & Trust opened a new position in Merck (MRK) in Q2 2026: 83,853 shares worth $10.8M. The stake represents 0.91% of the portfolio and ranks #23 among its holdings. This is a return to the name: Canandaigua National Bank & Trust previously reported a position in MRK as recently as Q4 2025.

Canandaigua National Bank & Trust first reported a position in MRK in Q2 2013 and has held it in 41 quarters since. The position peaked at $11M in Q1 2023. 2,018 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Canandaigua National Bank & Trust held 83,853 shares of Merck worth $10.8M as of Q2 2026.
  • Merck was a new Canandaigua National Bank & Trust position in Q2 2026.
  • Merck made up 0.91% of Canandaigua National Bank & Trust's portfolio in Q2 2026, its #23 holding.
  • Canandaigua National Bank & Trust first reported a position in Merck in Q2 2013 and has held it in 41 quarters since.
  • Canandaigua National Bank & Trust's Merck position peaked at $11M in Q1 2023.
  • 2,018 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Canandaigua National Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.